Epsin-1 (EPN1) is a pivotal endocytic adaptor protein that orchestrates clathrin-mediated endocytosis (CME) at the presynaptic terminal. As a member of the epsin family, EPN1 contains multiple protein-protein interaction domains that enable it to coordinate vesicle formation, cargo selection, and membrane curvature during synaptic vesicle recycling [@itoh2001]. Its critical role in neuronal endocytosis has made it a protein of interest in [Alzheimer's disease](/diseases/alzheimers-disease) research, particularly regarding [amyloid precursor protein (APP)](/proteins/amyloid-beta) trafficking and processing.
Structure
EPN1 possesses a modular architecture comprising several functional domains:
Epsin-1 (EPN1) is a pivotal endocytic adaptor protein that orchestrates clathrin-mediated endocytosis (CME) at the presynaptic terminal. As a member of the epsin family, EPN1 contains multiple protein-protein interaction domains that enable it to coordinate vesicle formation, cargo selection, and membrane curvature during synaptic vesicle recycling [@itoh2001]. Its critical role in neuronal endocytosis has made it a protein of interest in [Alzheimer's disease](/diseases/alzheimers-disease) research, particularly regarding [amyloid precursor protein (APP)](/proteins/amyloid-beta) trafficking and processing.
Structure
EPN1 possesses a modular architecture comprising several functional domains:
ENTH Domain (Epsin N-terminal Homology): The N-terminal domain that binds phosphatidylinositol (PIs) and initiates membrane curvature
DPF Motifs: Multiple DPF (Asp-Pro-Phe) sequences that interact with clathrin coats
DPW Motifs: Additional clathrin-binding sequences
NRG Tripeptide: Critical for interaction with the ubiquitin-interacting motifs
EPN1 levels in cerebrospinal fluid may reflect synaptic dysfunction
Altered EPN1 phosphorylation in AD brains
Drug Target
Epsin inhibitors under investigation for cancer also potential for AD
[Blood-brain barrier](/entities/blood-brain-barrier) penetration required for CNS applications
Summary
EPN1 is a critical endocytic adaptor protein that regulates clathrin-mediated synaptic vesicle recycling and APP trafficking. Its role in directing APP to amyloidogenic compartments makes it a relevant target for Alzheimer's disease therapeutics. Modulating EPN1 function could reduce Aβ production while preserving essential synaptic functions.